A Bayesian Approach to the Design of Phase II Clinical Trials

Recommendations

Approximately optimal designs for phase II clinical studies
Sample Size Determination for Phase II Clinical Trials Based on Bayesian Decision Theory
A Bayesian decision approach for sample size determination in phase II trials
Bayesian Optimal Design for Phase II Screening Trials
Decision-Theoretic Designs for Phase II Clinical Trials Allowing for Competing Studies

Cited in

(48)

Bayes rules for a clinical-trials model with dichotomous responses
Optimal Bayesian two-phase designs
Bayesian statistics and the efficiency and ethics of clinical trials
Is the FDA too conservative or too aggressive?: a Bayesian decision analysis of clinical trial design
Randomized phase III oncology trials: a survey and empirical Bayes inference
Bayesian design for clinical trials with a constraint on the total available dose
Bayesian enrichment strategies for randomized discontinuation trials
Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes
A Bayesian decision approach for sample size determination in phase II trials
An optimal Bayesian predictive probability design for phase II clinical trials with simple and complicated endpoints
Use of bayesian analysis to design of clinical trials with one treatment
Bayesian approach to determine the number of subsequent users of a new treatment
Sample sizes of clinical trials: for science and decision making
Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome
scientific article; zbMATH DE number 4155731 (Why is no real title available?)
Bayesian Optimal Design for Phase II Screening Trials
Bayesian Design and Analysis of Two x Two Factorial Clinical Trials
scientific article; zbMATH DE number 1990010 (Why is no real title available?)
MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION
Approximately optimal designs for phase II clinical studies
Bayesian enhancement two-stage design for single-arm phase II clinical trials with binary and time-to-event endpoints
Motivating sample sizes in adaptive phase I trials via Bayesian posterior credible intervals
Decision-theoretic designs for a series of trials with correlated treatment effects using the Sarmanov multivariate beta-binomial distribution
Bayesian designs for phase I--II clinical trials
Approaches for Optimal Sequential Decision Analysis in Clinical Trials
Bayesian Design and Analysis of Active Control Clinical Trials
Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes
Bayesian randomized clinical trials: A decision-theoretic sequential design
Bayesian Approaches to Randomized Trials
Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design
Practical Bayesian Guidelines for Phase IIB Clinical Trials
scientific article; zbMATH DE number 863809 (Why is no real title available?)
Design and Analysis of Phase II Cancer Trials: A Review of Statistical Methods and Guidelines for Medical Researchers
A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups
Bayesian design of biosimilars clinical programs involving multiple therapeutic indications
A Bayesian seamless phase I–II trial design with two stages for cancer clinical trials with drug combinations
Monitoring futility and efficacy in phase II trials with Bayesian posterior distributions—A calibration approach
Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials
Determination of the optimal sample size for a clinical trial accounting for the population size
Bayesian designs with frequentist and Bayesian error rate considerations
scientific article; zbMATH DE number 5224906 (Why is no real title available?)
Implementation of a Bayesian Design in a Dose‐Escalation Study of an Experimental Agent in Healthy Volunteers
On an approach to Bayesian sample sizing in clinical trials
A Bayesian adaptive phase I/II clinical trial design with late‐onset competing risk outcomes
Bayesian design of clinical trials using joint cure rate models for longitudinal and time-to-event data
Adaptive data collection for intraindividual studies affected by adherence
Bayesian doubly adaptive randomization in clinical trials
An approach to design adaptive clinical trials with time-to-event outcomes based on a general Bayesian posterior distribution

This page was built for publication: A Bayesian Approach to the Design of Phase II Clinical Trials

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3201545)